phosphoserine has been researched along with tromethamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, C; Feng, J; Sandmeyer, JL; Sellke, FW | 1 |
| Balu-Iyer, SV; Fathallah, AM; Mager, DE; Turner, MR | 1 |
2 other study(ies) available for phosphoserine and tromethamine
| Article | Year |
|---|---|
Bradykinin preconditioning improves the profile of cell survival proteins and limits apoptosis after cardioplegic arrest.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Bradykinin; Caspase 3; Caspases; Cell Survival; Drug Evaluation; Enzyme Activation; Glucose; Heart Arrest, Induced; In Situ Nick-End Labeling; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Myocardium; Phosphorylation; Phosphoserine; Positive-Pressure Respiration; Potassium Compounds; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Rabbits; Tromethamine | 2005 |
Effects of hypertonic buffer composition on lymph node uptake and bioavailability of rituximab, after subcutaneous administration.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Biological Availability; Buffers; Hypertonic Solutions; Injections, Subcutaneous; Lymph Nodes; Male; Mannitol; Mice; Phosphoserine; Rituximab; Sodium Chloride; Tromethamine | 2015 |